tidytlg
A tables-listings-graphs package that reached CRAN and then went quiet.
A side-by-side editorial comparison of datefixR and DoseFinding — release velocity, themes, recent moves, and the top alternatives to consider.
The messy-date parser rewrote its core in Rust and came out 300x faster.
datefixR standardizes inconsistently formatted dates — the kind that arrive from spreadsheets and hand-entered clinical or survey data, with mixed separators, ambiguous orders, missing components, and month names in whatever language the source used. Version 2.0.0 rewrote the parsing core in Rust, reporting over 300x throughput against previous versions through fastpath handling of common formats and parallel column processing via a cores argument. Version 2.0.1 then spent itself cleaning up after that rewrite, restoring ordinal indicator support, stopping malformed dates from being silently cast to NA, and reinstating error messages that had gone missing.
New stewardship at openpharma, then two releases adding the methods MCP-Mod was missing
DoseFinding implements MCP-Mod and related dose-response methodology for clinical trial design and analysis. In 2024 it changed hands — Marius Thomas took over as maintainer, Novartis was recorded as copyright holder and funder, and the package moved to the openpharma GitHub organisation with roxygen documentation and a proper NEWS file. The two releases since have added substantive methodology: model averaging for dose-response fitting in 1.3-1, and conditional and predictive power for interim analyses in 1.4-1.
datefixR standardizes inconsistently formatted dates — the kind that arrive from spreadsheets and hand-entered clinical or survey data, with mixed separators, ambiguous orders, missing components, and month names in whatever language the source used. Version 2.0.0 rewrote the parsing core in Rust, reporting over 300x throughput against previous versions through fastpath handling of common formats and parallel column processing via a cores argument. Version 2.0.1 then spent itself cleaning up after that rewrite, restoring ordinal indicator support, stopping malformed dates from being silently cast to NA, and reinstating error messages that had gone missing.
Two long arcs meet here. The first is localization: Russian, Indonesian, German, Spanish month abbreviations, and experimental Roman numeral months accumulated release by release, with full translation of user-facing messages treated as a goal rather than a bonus. The second is the migration off R for the parsing hot path — internals began moving to C++ around 1.3.1 before the Rust rewrite replaced that work entirely. The 2.0.1 regressions show the cost of that move, since behavior that was implicit in the R implementation had to be re-specified.
The Rust core is one release into stabilization and 2.0.1 was entirely regression repair, so expect further correctness fixes against pre-2.0.0 behavior before any new format support lands.
DoseFinding implements MCP-Mod and related dose-response methodology for clinical trial design and analysis. In 2024 it changed hands — Marius Thomas took over as maintainer, Novartis was recorded as copyright holder and funder, and the package moved to the openpharma GitHub organisation with roxygen documentation and a proper NEWS file. The two releases since have added substantive methodology: model averaging for dose-response fitting in 1.3-1, and conditional and predictive power for interim analyses in 1.4-1.
The pattern before the handover was maintenance — R-devel compliance, a bug fix, a link. After it, each release carries a named methodological addition with an acknowledged contributor, plus documentation to match: a longitudinal analysis vignette shipped alongside the interim power work. Housekeeping continues underneath, mostly clearing deprecated ggplot2 interfaces, aes_string in one release and qplot in the next.
Given the last two releases each added one method with a supporting vignette, expect the next to follow the same shape. Both additions so far extend the package beyond fixed dose-response fitting, so adaptive and interim methodology is the more likely direction.
Other Analytics products tracked by Sparkpulse, ranked by recent ship velocity. Each card links to a full editorial trajectory and lets you pivot into a head-to-head comparison with either datefixR or DoseFinding.
A tables-listings-graphs package that reached CRAN and then went quiet.
Tplyr made clinical summary tables explain where every number came from.
Clinical listings that keep inheriting their hardest problem — pagination — from the layer below.
A cache-directory helper that has shipped nothing but CRAN-triggered patches for seven years.
gigs redesigned its whole conversion API for rOpenSci, then spent three releases getting the docs to build.
A weather-data client that keeps rewriting its HTTP layer while slowly tightening its API.
See all datefixR alternatives → · See all DoseFinding alternatives →
Latest ship moves from both products, interleaved chronologically. ⚡ = editorial spark.
They serve adjacent needs but don't currently overlap on shipped themes. datefixR and DoseFinding are shipping at a similar cadence (velocity 0.0 vs 0.0, both within Sparkpulse's "active" band). See the at-a-glance table above for a side-by-side breakdown of velocity, recent sparks, and editorial themes.
Sparkpulse doesn't pick a winner — we score release velocity, not feature parity. datefixR and DoseFinding are shipping at a similar cadence (velocity 0.0 vs 0.0, both within Sparkpulse's "active" band). For your specific use case, the alternatives sections above list other Analytics products to evaluate alongside.
Top datefixR alternatives in Analytics are ranked by recent ship velocity. Browse the "datefixR alternatives" section above for the current picks, or visit /alternatives/datefixr for the full list with editorial commentary on each.
Top DoseFinding alternatives in Analytics are ranked by recent ship velocity. Browse the "DoseFinding alternatives" section above for the current picks, or visit /alternatives/dosefinding for the full list with editorial commentary on each.